Intelligent Medicine Acquisition Stock Beta
| IQMDWDelisted Stock | USD 0 0.00 0.00% |
Intelligent Medicine Acquisition fundamentals help investors to digest information that contributes to Intelligent Medicine's financial success or failures. It also enables traders to predict the movement of Intelligent Stock. The fundamental analysis module provides a way to measure Intelligent Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intelligent Medicine stock.
Intelligent |
Intelligent Medicine Acquisition Company Beta Analysis
Intelligent Medicine's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Intelligent Medicine Acquisition has a Beta of 0.0. This is 100.0% lower than that of the Financial Services sector and about the same as Shell Companies (which currently averages 0.0) industry. The beta for all United States stocks is 100.0% lower than that of the firm.
Intelligent Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intelligent Medicine's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intelligent Medicine could also be used in its relative valuation, which is a method of valuing Intelligent Medicine by comparing valuation metrics of similar companies.Intelligent Medicine is currently under evaluation in beta category among its peers.
Intelligent Fundamentals
| EBITDA | (14.54 M) | |||
| Net Income | 11.41 M | |||
| Cash And Equivalents | 69.33 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 165 K | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (866.9 K) | |||
| Total Asset | 214.03 M | |||
| Retained Earnings | (10.86 M) | |||
| Working Capital | (891.12 K) | |||
| Z Score | -0.3 | |||
| Net Asset | 214.03 M |
About Intelligent Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intelligent Medicine Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelligent Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelligent Medicine Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Intelligent Stock
If you are still planning to invest in Intelligent Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intelligent Medicine's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |